- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13:20 | J&J warns biosimilars will bite after muted impact in 2019 | ||
| Di | Bellicum offloads cell therapy plant in switch to outsourced production | ||
| Di | Lonza poised to add 600 staff as investment peak continues into 2020 | ||
| Di | Krystal Biotech continues internal buildout with second facility | ||
| Mo | New CDMO plans $1.1bn cell and gene therapy plant | ||
| Fr | Large pharma focusing on in-house biologic manufacture, not outsourcing | ||
| Do | GE Healthcare anticipates demand with Swiss facility investment | ||
| Do | PACT Pharma raises $75M to expand cell therapy manufacturing | ||
| 22.01. | Number of UK clinical trials of cell and gene therapies explodes | ||
| 22.01. | Celltrion set to build largest biopharma plant in China | ||
| 22.01. | Health plan hails success of push to boost Remicade biosimilar use | ||
| 21.01. | Sarepta tips Roche pact to spur manufacturing capacity expansion | ||
| 20.01. | Merck looks to CMOs to help ease vaccine supply bottleneck | ||
| 20.01. | Nationwide Children's Hospital creates for-profit gene therapy CMO | ||
| 17.01. | Failure to launch? Mixed views on US biosimilar market | ||
| 16.01. | WuXi Biologics acquires first EU drug product facility through Bayer deal | ||
| 16.01. | Commercial manufacture of Bluebird's gene therapy begins, launched in Germany | ||
| 15.01. | Astellas continues to make deals, partnering with Adaptimmune | ||
| 15.01. | Lilly acquires Dermira for $1.1bn, expands dermatology portfolio | ||
| 14.01. | Biocon biosimilar business valued at $3bn in funding round | ||
| 14.01. | FDA places Innate cancer trial on partial clinical hold over CMO issue | ||
| 14.01. | Yposkesi doubles manufacturing footprint to meet growing demand on AAVs | ||
| 13.01. | Bristol-Myers offloads manufacturing plant to Catalent | ||
| 13.01. | Industry equipment is causing a 'data deficit', says Fujifilm exec | ||
| 09.01. | Astellas acquires Xyphos and its CAR-T technology for $665m |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
